Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Philippe Brouqui and Hervé Tissot-Dupont.
Philippe Brouqui
Connection Strength
0.990
Hervé Tissot-Dupont
  1. Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine? Travel Med Infect Dis. 2020 Mar - Apr; 34:101624.
    View in: PubMed
    Score: 0.218
  2. Prevalence of skin infections in sheltered homeless. Eur J Dermatol. 2005 Sep-Oct; 15(5):382-6.
    View in: PubMed
    Score: 0.080
  3. Implementation of an in-house real-time reverse transcription-PCR assay for the rapid detection of the SARS-CoV-2 Marseille-4 variant. J Clin Virol. 2021 06; 139:104814.
    View in: PubMed
    Score: 0.059
  4. Evaluating the serological status of COVID-19 patients using an indirect immunofluorescent assay, France. Eur J Clin Microbiol Infect Dis. 2021 Feb; 40(2):361-371.
    View in: PubMed
    Score: 0.057
  5. Olfactory and gustative disorders for the diagnosis of COVID-19. Travel Med Infect Dis. 2020 Sep - Oct; 37:101875.
    View in: PubMed
    Score: 0.056
  6. Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults. Eur J Clin Microbiol Infect Dis. 2020 Oct; 39(10):1983-1987.
    View in: PubMed
    Score: 0.056
  7. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Med Infect Dis. 2020 Jul - Aug; 36:101791.
    View in: PubMed
    Score: 0.056
  8. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020 May - Jun; 35:101738.
    View in: PubMed
    Score: 0.055
  9. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul; 56(1):105949.
    View in: PubMed
    Score: 0.055
  10. Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot. Travel Med Infect Dis. 2020 Jul - Aug; 36:101632.
    View in: PubMed
    Score: 0.055
  11. Emergence of uncommon HIV-1 non-B subtypes and circulating recombinant forms and trends in transmission of antiretroviral drug resistance in patients with primary infection during the 2013-2015 period in Marseille, Southeastern France. J Med Virol. 2018 10; 90(10):1559-1567.
    View in: PubMed
    Score: 0.048
  12. Epidemiology of respiratory pathogen carriage in the homeless population within two shelters in Marseille, France, 2015-2017: cross sectional 1-day surveys. Clin Microbiol Infect. 2019 Feb; 25(2):249.e1-249.e6.
    View in: PubMed
    Score: 0.048
  13. Changing Demographics and Prevalence of Body Lice among Homeless Persons, Marseille, France. Emerg Infect Dis. 2017 11; 23(11):1894-1897.
    View in: PubMed
    Score: 0.046
  14. From Expert Protocols to Standardized Management of Infectious Diseases. Clin Infect Dis. 2017 Aug 15; 65(suppl_1):S12-S19.
    View in: PubMed
    Score: 0.046
  15. Toward chronic hepatitis C eradication in HIV-positive patients, including those cirrhotic and infected with genotype 3 viruses. Gut. 2017 10; 66(10):1868-1869.
    View in: PubMed
    Score: 0.044
  16. Prevalence of antibodies to Rickettsia conorii Ricketsia africae, Rickettsia typhi and Coxiella burnetii in Mauritania. Eur J Epidemiol. 1998 Dec; 14(8):817-8.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.